Publication:
XENON in medical area: emphasis on neuroprotection in hypoxia and anesthesia

dc.contributor.coauthorRobinot, Alexander
dc.contributor.coauthorZhang, John H.
dc.contributor.departmentSchool of Medicine
dc.contributor.facultymemberYes
dc.contributor.kuauthorEsencan, Ecem
dc.contributor.kuauthorSolaroğlu, İhsan
dc.contributor.kuauthorTosun, Yusuf Berk
dc.contributor.kuauthorYüksel, Simge
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T23:53:52Z
dc.date.issued2013
dc.description.abstractXenon is a medical gas capable of establishing neuroprotection, inducing anesthesia as well as serving in modern laser technology and nuclear medicine as a contrast agent. In spite of its high cost, its lack of side effects, safe cardiovascular and organoprotective profile and effective neuroprotective role after hypoxic-ischemic injury (HI) favor its applications in clinics. Xenon performs its anesthetic and neuroprotective functions through binding to glycine site of glutamatergic N-methyl-D-aspartate (NMDA) receptor competitively and blocking it. This blockage inhibits the overstimulation of NMDA receptors, thus preventing their following downstream calcium accumulating cascades. Xenon is also used in combination therapies together with hypothermia or sevoflurane. The neuroprotective effects of xenon and hypothermia cooperate synergistically whether they are applied synchronously or asynchronously. Distinguishing properties of Xenon promise for innovations in medical gas field once further studies are fulfilled and Xenon's high cost is overcome.
dc.description.fulltextNo
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.indexedbyPubMed
dc.description.openaccessYES
dc.description.peerreviewstatusN/A
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.studentonlypublicationNo
dc.description.studentpublicationYes
dc.description.versionN/A
dc.identifier.WoSQuartileQ2
dc.identifier.doi10.1186/2045-9912-3-4
dc.identifier.embargoN/A
dc.identifier.issn2045-9912
dc.identifier.pubmed23369273
dc.identifier.urihttps://doi.org/10.1186/2045-9912-3-4
dc.identifier.urihttps://hdl.handle.net/20.500.14288/15093
dc.identifier.volume3
dc.identifier.wos000215734900004
dc.keywordsXenon
dc.keywordsHypoxia
dc.keywordsIschemia
dc.keywordsNeuroprotection
dc.keywordsAnesthesia
dc.keywordsHypothermia
dc.keywordsNMDA
dc.language.isoeng
dc.publisherWolters Kluwer
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofMedical Gas Research
dc.relation.openaccessN/A
dc.rightsN/A
dc.subjectMedicine
dc.subjectExperimental medicine
dc.titleXENON in medical area: emphasis on neuroprotection in hypoxia and anesthesia
dc.typeReview
dspace.entity.typePublication
local.contributor.kuauthorEsencan, Ecem
local.contributor.kuauthorYüksel, Simge
local.contributor.kuauthorTosun, Yusuf Berk
local.contributor.kuauthorSolaroğlu, İhsan
relation.isGoalOfPublicationa9786601-9431-4553-9a46-013bb366fb87
relation.isGoalOfPublication.latestForDiscoverya9786601-9431-4553-9a46-013bb366fb87
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files